BD Posiflush Pre-Filled Normal Saline Syringes Catalog Number: 306575 (Canada only)
Published November 27, 2019 · Recall initiated: October 14, 2019
Summary
FDA records medical device Class II recall Z-0500-2020, published November 27, 2019 and initiated October 14, 2019. Recalling firm: Becton Dickinson & Company; Status: Terminated; Reported quantity: 967,680; Lot: Lot Number: 9175971 UDI: 50382903065757. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Limited number of syringes labeled Posiflush Experimental Product and Not for Human Use being mixed with standard BD Posiflush Pre-Filled Normal Saline Syringes.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Becton Dickinson & Company
- Distributor
- Distribution US Nationwide and Canada
- Lot
- Lot Number: 9175971 UDI: 50382903065757
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDABD®Spinal Tray with BD®Whitacre Needle 25 G x 3.5 in.; lidocaine HCL (1%), 5 mL, bupivacaine HCL (0.75%) withJune 10, 2026
- FDABD®Spinal Tray with BD®Quincke Needle 26 G x 3.5 in.; lidocaine HCL (1%), 5 mL, bupivacaine HCL (0.75%) withJune 10, 2026
- FDABD®Spinal Tray with BD®Whitacre Needle 22 G x 3.5 in.; lidocaine HCL (1%), 5 mL, bupivacaine HCL (0.75%) withJune 10, 2026
- FDABD®Spinal Tray with BD®Whitacre Needle 25 G x 3.5 in.; lidocaine HCL (1%), 2 mL, bupivacaine HCL (0.75%) withJune 10, 2026
- FDATorcon NB Advantage Catheters - Product Usage: Intended for use in the peripheral and coronary vascularNovember 27, 2019
- FDABIOFLO 8F SINGLE TITANIUM NON- FILLED; VALVED, UPN H965440250, Cat. No. 44-025 - Product Usage: Long-termNovember 27, 2019
Questions about this recall
Was BD Posiflush Pre-Filled Normal Saline Syringes Catalog Number: 306575 (Canada only) recalled?
Yes. FDA published recall Z-0500-2020 on November 27, 2019. Reported hazard: Limited number of syringes labeled Posiflush Experimental Product and Not for Human Use being mixed with standard BD Posiflush Pre-Filled Normal Saline Syringes.
What should I do if I have this product?
Voluntary: Firm initiated · Letter